Biotalys NV (FRA:86C)
3.210
-0.050 (-1.53%)
At close: Jan 30, 2026
Biotalys NV Balance Sheet
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Cash & Equivalents | 15.71 | 22.64 | 21.57 | 34.1 | 56.11 | 23.1 |
Short-Term Investments | 2.11 | - | - | - | - | 2.1 |
Cash & Short-Term Investments | 17.82 | 22.64 | 21.57 | 34.1 | 56.11 | 25.2 |
Cash Growth | 21.40% | 4.95% | -36.74% | -39.23% | 122.62% | 7.90% |
Accounts Receivable | 0.54 | - | - | - | - | - |
Other Receivables | - | 0.97 | 0.75 | 0.82 | 0.45 | 0.23 |
Receivables | 0.54 | 0.97 | 0.75 | 0.82 | 0.45 | 0.23 |
Restricted Cash | - | 2.11 | 2.1 | 2.1 | 2.1 | - |
Other Current Assets | 0.76 | 0.52 | 0.49 | 0.75 | 0.28 | 0.08 |
Total Current Assets | 19.12 | 26.24 | 24.91 | 37.76 | 58.94 | 25.51 |
Property, Plant & Equipment | 6.08 | 6.81 | 8.43 | 9 | 9.29 | 8.96 |
Other Intangible Assets | 0.55 | 0.57 | 0.64 | 0.6 | 0.67 | 0.79 |
Long-Term Deferred Tax Assets | 0.01 | 0.01 | 0.02 | 0.13 | - | - |
Other Long-Term Assets | 3.23 | 3.11 | 2.58 | 2.03 | 1.38 | 1 |
Total Assets | 28.99 | 36.75 | 36.58 | 49.52 | 70.27 | 36.26 |
Accounts Payable | 2.58 | 1.17 | 1.25 | 2.73 | 1.93 | 3.3 |
Accrued Expenses | - | 1.52 | 1.33 | 1.39 | 1.18 | - |
Current Portion of Long-Term Debt | 1.1 | 0.44 | 0.43 | 0.42 | 0.42 | 0.08 |
Current Portion of Leases | - | 0.71 | 0.8 | 0.74 | 0.77 | 0.81 |
Current Unearned Revenue | 1.62 | - | 1.72 | 0.59 | 0.9 | - |
Other Current Liabilities | - | 0.93 | 0.01 | 0.08 | 0 | 1.96 |
Total Current Liabilities | 5.29 | 4.77 | 5.55 | 5.96 | 5.21 | 6.15 |
Long-Term Debt | 1.14 | 2.02 | 2.46 | 2.89 | 3.31 | 1.14 |
Long-Term Leases | 2.06 | 1.68 | 2.39 | 2.45 | 2.73 | 3.2 |
Long-Term Unearned Revenue | 0.51 | - | 0.51 | - | - | - |
Pension & Post-Retirement Benefits | 0.08 | 0.08 | 0.02 | 0.02 | 0.03 | 0.05 |
Other Long-Term Liabilities | 0.09 | 0.6 | 0.09 | 0.09 | 0.09 | 0.09 |
Total Liabilities | 9.18 | 9.14 | 11.01 | 11.4 | 11.36 | 10.61 |
Common Stock | 5.54 | 5.54 | 46.2 | 44.55 | 81.97 | 62.82 |
Additional Paid-In Capital | 29.23 | 29.21 | 15.49 | 10.16 | 31.3 | 0.68 |
Retained Earnings | -19.88 | -11.8 | -40.2 | -19.66 | -55.86 | -34.12 |
Comprehensive Income & Other | 4.92 | 4.66 | 4.08 | 3.06 | 1.5 | -3.73 |
Shareholders' Equity | 19.81 | 27.61 | 25.57 | 38.11 | 58.92 | 25.65 |
Total Liabilities & Equity | 28.99 | 36.75 | 36.58 | 49.52 | 70.27 | 36.26 |
Total Debt | 4.29 | 4.85 | 6.07 | 6.5 | 7.22 | 5.22 |
Net Cash (Debt) | 13.53 | 17.79 | 15.5 | 27.6 | 48.88 | 19.98 |
Net Cash Growth | 47.13% | 14.80% | -43.84% | -43.55% | 144.63% | -11.63% |
Net Cash Per Share | 0.38 | 0.53 | 0.49 | 0.89 | 3.17 | 26.64 |
Filing Date Shares Outstanding | 37.47 | 37.47 | 32.09 | 30.96 | 30.85 | 0.75 |
Total Common Shares Outstanding | 37.47 | 37.47 | 32.09 | 30.95 | 30.81 | 0.75 |
Working Capital | 13.82 | 21.47 | 19.36 | 31.8 | 53.73 | 19.36 |
Book Value Per Share | 0.53 | 0.74 | 0.80 | 1.23 | 1.91 | 34.20 |
Tangible Book Value | 19.26 | 27.03 | 24.93 | 37.52 | 58.25 | 24.86 |
Tangible Book Value Per Share | 0.51 | 0.72 | 0.78 | 1.21 | 1.89 | 33.14 |
Machinery | - | 4.85 | 4.35 | 3.63 | 2.9 | - |
Construction In Progress | - | - | - | - | - | 2.81 |
Leasehold Improvements | - | 3.44 | 3.43 | 3.39 | 3.31 | 1.83 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.